These results suggest that CTRP1 plays multiple roles in various tissues and pathological conditions, and the therapeutical role of CTRP1 in treating obesity, type II diabetes, and fatty liver remains elusive, as well as their underlying mechanisms. This evidence concerns the gene C1QTNF1 and obesity due to melanocortin 4 receptor deficiency.